Female Stress Urinary Incontinence Treatment Devices Market Analysis

End-user (Hospitals, Gynecological Clinics, Home Care Settings)

The global female stress urinary incontinence treatment devices market is segmented and analyzed for demand and supply by end-user in hospitals, gynecological clinics, and home care settings. Out of these end users, the hospital segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the presence of developed healthcare infrastructure and the availability of a huge medical force, labs, and other equipment in a single place. The total number of all U.S hospitals was estimated to be about 6,093 in 2022. Whereas, in the type segment, the electrical stimulation devices sub-segment holds the largest market share of 54.42% as of 2022, owing to their ease of operation, and cost-effectiveness with the great convenience of being self-administered at home. Furthermore, hospitals are noticed to provide better medical care for women with PCOS. For instance, it has been observed that around 20% of women globally get hospitalized owing to PCOS.

Type (Urethral Sling, Artificial Urinary Sphincters, Electrical Stimulation Devices, Catheters)

The global female stress urinary incontinence treatment devices market is also segmented and analyzed for demand and supply by type into the urethral sling, artificial urinary sphincters, electrical stimulation devices, and catheters. Amongst these segments, the urethral sling segment is expected to garner a significant share. A urethral sling is a surgery that is performed to treat to treat stress urinary incontinence. The sling is placed in the urethra to support it and to carry urine from the bladder to discharge it. It is observed that approximately 75% of incontinence cases are completely cured after surgery while many cases don’t even require sling surgery. Hence, such factors are expected to hike the growth of the segment over the forecast period.

Our in-depth analysis of the global market includes the following segments:

By Type	Urethral Sling Artificial Urinary Sphincters Electrical Stimulation Devices Catheters
By Product Type	Sling Systems Pessaries Injectable Urethral Bulking Agents
By End-User	Hospitals Gynecological Clinics Home Care Settings

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of female stress urinary incontinence treatment devices is assessed at USD 745.79 Million.

The female stress urinary incontinence treatment devices market size was over USD 704.24 Million in 2023 and is likely to reach USD 1.48 Billion by the end of 2036, growing at around 5.9% CAGR during the forecast period i.e., between 2024-2036. Increase in instances of urinary incontinence and growing incidence of urinary incontinence due to menopause are the major factors driving the market growth.

North America is poised to account for majority industry share by 2036, attributed to well-established healthcare infrastructure boosted by investment and growing R&D of drugs and medications.

Boston Scientific Corporation, Johnson & Johnson Services, Inc., Becton, Dickinson and Company, Coloplast Corp., CooperSurgical, Inc., MedGyn Products, Inc., Caldera Medical, Inc, FEG Textiltechnik mbH, Medical Device Business Services, Inc., Renovia Inc.

Female Stress Urinary Incontinence Treatment Devices Market Analysis